ISRCTN16535341已完成未知
Adults undergoing major lung surgery randomised to nutritional intervention or equivalent volume in water to assess the effects on post-operative outcomes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
2021 Preprint results in https://www.medrxiv.org/content/10.1101/2021.09.08.21263295v1?ct= non-peer-reviewed results (added 21/09/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35768119/ (added 30/06/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients, aged over 18
- •2. Undergoing elective major lung surgery (MLS)
- •3. Able to consume nutritional drinks prior to surgery
- •4. Able to give written informed consent
排除标准
- •1. Likely inability to comply with completion of the study questionnaires
- •2. Body mass index (BMI) < 18.5 kg/m2
- •3. Receiving enteral nutrition
- •4. Known pregnancy
研究者
相似试验
已完成
不适用
The role of protective intra-operative ventilation with alveolar recruitment strategies in minimising acute lung injury in lung transplantation.ung transplantationrespiratoryLung transplantationAnaesthesiology - AnaestheticsRespiratory - Other respiratory disorders / diseasesACTRN12612000403831Alfred Health33
Unknown
不适用
Study to Assess the Effectiveness of Transcollation Technology to Reduce Bleeding in Lung SurgeryBlood Loss, SurgicalNCT02631889University of Roma La Sapienza170
已完成
不适用
Prospective observational results of pulmonary resection for over 75 years-old patients with non-small cell lung cancer - Multi-institutional study in Japanon-small cell lung cancerJPRN-UMIN000021904Dept. General Thoracic Surgery, National Hospital Organization Beppu Medical Center275
终止
2 期
Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboLung CancerNCT00538681Eli Lilly and Company35
已完成
不适用
Prophylactic Noninvasive Ventilation in vs Postoperative Standard Care in High Risk Patients According to ARISCAT ScoreSurgical PatientsPulmonary ComplicationNCT03629431Institut Cancerologie de l'Ouest266